CD5 and lymphoproliferative syndrome: The analysis of missed cases identified specific immunophenotypic features that challenge the DNN’s classification abilities, particularly CD5-negative B-cell neoplasms (5/13) and lymphoproliferative disorders with atypical immunophenotypes (7/13), with only one classic CLL case missed due to low event counts just below our threshold.